ArticleEuropean heart journal. Digital health2026
An Artificial Intelligence based model for predicting long-term all-cause mortality after acute Myocardial Infarction (the AIMI model).
Article in European heart journal. Digital health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aims: Predicting long-term mortality after acute myocardial infarction (AMI) remains challenging. We aimed to establish an Artificial Intelligence-based model for predicting long-term all-cause mortality after AMI (the AIMI model). Methods and results: AIMI model was employed by RF (Random forest). Individual predictions were visualized by SHAP plots. AIMI model was compared against existing clinical risk scores using time-dependent ROC (receiver operating characteristic) curves, and Kaplan-Meier (K-M) analyses. External validation was also performed at the same way. Brier scores were calculated in validation cohorts. We consecutively enrolled 4825 AMI patients underwent emergent coronary angiography or PCI procedures within 24 h of symptom onset to train and test the AIMI model and 723 AMI patients for external validation. Model incorporated 15 variables achieved robust performance (C-index = 0.81). As indicated by AUCs in the test set, AIMI model outperformed GRACE and TIMI risk scores across short-, mid- and long-term periods, especially for long-term prediction (1, 3 and 5 years). K-M curves confirmed precise discrimination between low-, median-, and high-risk groups (all Conclusion: The AIMI model surpassed traditional methods for long-term all-cause death prediction after AMI. AI-based model demonstrated potential to enhance risk stratification and guide post-discharge management.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.